Cabozantinib Real-World Effectiveness for the Treatment of Metastatic RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cabozantinib Real-World Effectiveness in the First-Through Fourth-Line Settings for the Treatment of Metastatic Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Cancer Med 2021 Jan 18;[EPub Ahead of Print], CL Gan, S Dudani, JC Wells, F Donskov, SK Pal, N Dizman, N Rathi, B Beuselinck, F Yan, AA Lalani, A Hansen, B Szabados, G de Velasco, B Tran, JL Lee, UN Vaishampayan, GA Bjarnason, M Subasri, TK Choueiri, DYC HengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.